Cargando…
Potential miRNA Use as a Biomarker: From Breast Cancer Diagnosis to Metastasis
Breast cancer is the most common cancer in women. Despite advances in diagnosis and prognosis, distal metastases occur in these patients in up to 15% of cases within 3 years of diagnosis. The main organs in which BC metastasises are the bones, lungs, liver, and brain. Unfortunately, 90% of metastati...
Autores principales: | Jordan-Alejandre, Euclides, Campos-Parra, Alma D., Castro-López, Dora Luz, Silva-Cázares, Macrina Beatriz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954167/ https://www.ncbi.nlm.nih.gov/pubmed/36831192 http://dx.doi.org/10.3390/cells12040525 |
Ejemplares similares
-
Molecular Pathways Related to Sulforaphane as Adjuvant Treatment: A Nanomedicine Perspective in Breast Cancer
por: Saavedra-Leos, María Zenaida, et al.
Publicado: (2022) -
Nanomaterial Complexes Enriched With Natural Compounds Used in Cancer Therapies: A Perspective for Clinical Application
por: Saavedra-Leos, María Zenaida, et al.
Publicado: (2021) -
Editorial: Strategic molecular biomarkers and microRNAs in cancer
por: López-Camarillo, César, et al.
Publicado: (2022) -
Bioinformatic miRNA-mRNAs Analysis Revels to miR-934 as a Potential Regulator of the Epithelial–Mesenchymal Transition in Triple-Negative Breast Cancer
por: Contreras-Rodríguez, Jorge Alberto, et al.
Publicado: (2023) -
Novel Insights into Circular RNAs in Metastasis in Breast Cancer: An Update
por: Zepeda-Enríquez, Paola, et al.
Publicado: (2023)